MemoDero Overview
- Year Founded
-
2015
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
MemoDero General Information
Description
Developer of PTSD (Post-traumatic stress disorder) drug intended for stress disorder. The company develops drugs to prevent debilitating consequences of fear-related diseases such as post-traumatic, enabling patients to overcome fear memory following a traumatic event.
Contact Information
Corporate Office
- Abba Khoushy Avenue 199
- Haifa
- Israel
Corporate Office
- Abba Khoushy Avenue 199
- Haifa
- Israel
MemoDero Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Feb-2022 | Completed | Out of Business | |||
| 1. Seed Round | 01-Jan-2019 | Completed | Generating Revenue |
MemoDero Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MemoDero FAQs
-
When was MemoDero founded?
MemoDero was founded in 2015.
-
Who is the founder of MemoDero?
Raphael Lamprecht is the founder of MemoDero.
-
Where is MemoDero headquartered?
MemoDero is headquartered in Haifa, Israel.
-
What industry is MemoDero in?
MemoDero’s primary industry is Drug Discovery.
-
Is MemoDero a private or public company?
MemoDero is a Private company.
-
What is MemoDero’s current revenue?
The current revenue for MemoDero is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
